SOURCE: Press Ventures

September 06, 2013 17:00 ET

Press Ventures and Biosafety Systems Inc. Announce CLO-D for Testing With Environmental Protection Agency in the U.S.

WARSAW, POLAND--(Marketwired - Sep 6, 2013) - Press Ventures Inc. (OTCQB: PVEN) ("Press Ventures" or the "Company"), is pleased to announce that the Company, through its wholly-owned subsidiary Biosafety Systems, Inc. ("Biosafety Systems"), is in the process of submitting applications for rigorous testing of its patented natural cedar oil based biosafety technology in the United States with the federal Environmental Protection Agency ("EPA"). The testing is designed to allow the EPA to confirm the effectiveness of the Company's patented Cedar Leaf Oil Diffusion ("CLO-D") system through the testing period. The effectiveness of the CLO-D technology has previously been proven and published in an international scientific journal by Dr. Jim Hudson, a renowned virologist and pathologist.

Following the EPA testing and anticipated approval, Biosafety Systems will have access to the world's largest single biosafety marketplace and the ability to target sales and marketing efforts towards key industries including poultry farms, meat processors, commercial buildings, and other high-risk structures which have known vulnerabilities as active breeding grounds for the spread of deadly bacteria and viruses. The commercial building biosafety sector in the United States is estimated at $3 billion annually. The movement towards "green" buildings and LEED certification is expected to significantly assist the Company to rapidly install the CLO-D technology into many new and existing buildings. Mr. Edward Denkiewicz, CEO Press Ventures and BioSafety Systems, commented, "The outbreak of new airborne viruses and deadly bacteria are becoming more commonplace and represent a true global emergency. Laboratory and real world testing has already proven the patented science behind CLO-D and its effectiveness at protecting against well-known dangerous bacteria and viruses like H1N1, Avian Bird Flu, SARS, and Legionnaires Disease to name a few. We look forward to the successful conclusion of the new EPA testing process and direct access to the U.S. marketplace for the rollout of CLO-D biosafety systems across the entire country."

About Press Ventures

Press Ventures owns the worldwide rights to the patented Cedar Leaf Oil Diffusion ("CLO-D") technology for the use of natural non-human harming vapors to kill bacteria, mold, and viruses in buildings. The patented CLO-D technology has been shown to be capable of killing many deadly bacterial and viral substances such as anthrax and H1N1 in buildings while they are still occupied. The CLO-D technology has been laboratory and field tested and the Company believes that use of the technology can provide a marked improvement in air quality and eliminate many of the most dangerous airborne bacteria, viruses, and pollutants. For additional information about CLO-D technology and Press Ventures, please visit Investor Relations Contact:1-888-709-1550,

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, use of proceeds from the financing, demand for natural biosafety solutions, exploitation of business opportunities, strategic business goals, rise in diseases, capability of the Company's technology and market information. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products or technologies and operating as a development stage company, our ability to retain important members of our management team and attract other qualified personnel, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, our ability to develop and commercialize products based on our technology platform, and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at

Contact Information